On the contrary, miR-31 acts as an oncogenic miRNA in human lung cancer tissues by targeting specific tumor suppressors LATS2 (large tumor suppressor kinase 2) and PPP2R2A (protein phosphatase 2, regulatory subunit B, alpha). Here, LATS2 is linked to neoplasm.